Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Earnings Preview — 6848 total
VSAT enters its November 5 earnings release in an unusual position: a satellite communications company that has just delivered one of the sharpest weekly gains in its peer group, while simultaneously sitting at the…
Short interest in Extreme Networks has dropped to its lowest level in at least a year, with shorts covering at a pace running 1.6 standard deviations below the company's typical weekly move. That is the single most…
MDLN has lost 8.2% over the past month to close at $32.12, a steeper drop than nearly every name in its peer group, and the company reports Q3 results on November 4 with short sellers quietly covering even as the stock…
TEM reports Q3 results today with short sellers retreating even as the stock dropped 7.2% in a single session on October 30 before recovering 6.8% over the week, a swing that left it sharply outperforming correlated…
VNOM is one of the least crowded names among its Permian Basin peers heading into Monday's earnings release, with short interest at 6.2% of the free float against a lending market that remains extraordinarily…
PSNY reports Q3 results on November 5 carrying one of the most stressed borrow profiles in the EV sector, a shelf of measured registration data pointing in opposite directions, and an index overhang that could force…
IREN carries more short conviction than any of its closest peers, with 34.3% of free float borrowed against the stock, while WULF, CORZ, and RIOT each trade with significantly lighter short loads heading into…
The digital-finance sector is having a rough week, and Robinhood Markets is taking a harder knock than most of its neighbours. COIN dropped 10.6% on the day and 12.7% on the week. GEMI fell 6.8% on the day. IBKR shed…
AppLovin fell 12.2% over the past week, a move that stands well outside its peer group: the median weekly change across its closest correlated names ran at roughly minus 2.3%, with NXST and SIRI actually closing…
RVMD is a clinical-stage oncology company whose first commercial product, the RAS inhibitor Rasonque, received FDA approval for metastatic pancreatic cancer earlier this year. The company reports third-quarter results…
Datadog fell 12.7% over the past week to $235.27, a sharper move than any of its closest peers, with FTNT down 24.4% the notable exception and CRWD, PANW and FROG each dropping 2% to 6%. The selloff stands in direct…
Short sellers have built their largest position in FOXA in at least a year, with 24.2% of the free float now sold short. That figure has risen roughly 10% over the past month, driven by a step-change in borrowed shares…
MRNA has pulled back 11% over the past month among its closest biotech peers on short positioning, while the stock itself climbed 11% over the past week. Closest peer BNTX was flat on the week, NVAX gained roughly 4%,…
ROKU held up better than most of its closest peers in the past week, slipping 2.2% to $155.12 while the median decline across correlated names ran to 3.3%. DIS was roughly flat on the week, LYV added 2.6%, and CNVS…
KRYS enters its Q3 print with short sellers materially less committed than they were a month ago. Short interest has dropped 18% over the past 30 days to 9.9% of the free float, a decline that ORTEX measures as 3.2…
SPCX reports its next set of results on November 5, with the stock at $134.72 after falling nearly 9% over the past week and 10% over the past month, the sharpest pullback since the volatile post-debt-announcement…
Axsome Therapeutics has drifted 0.4% lower over the past week while its closest specialty pharma peers gained a median 3.4%. TARS rose 9.8% and HRMY added 7.3% over the same period. Even JAZZ managed a 0.9% gain.…
Short sellers have built a meaningful position in LITE ahead of Wednesday's fiscal first-quarter results, with short interest rising nearly 10% over the past week to reach 11.3% of the free float, one of the more…
NTRA reports Q3 results on November 5, with the stock at $414.30 after a 5% drop on October 30 wiped out most of a modest weekly gain, leaving shares roughly flat over the past month while the broader biotech peer…
FANG closes its books on another Permian Basin quarter with short sellers at their least aggressive in at least a year. Short interest has fallen 12% over the past month to 2.45% of the free float, the lowest reading…
